Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model.

Articles > Article · 2008

Authors: Devrim BOZKURT, HÜSEYİN TAŞKIN, Murat SEZAK, Selahattin BIÇAK, Sait ŞEN, Ercan OK, Soner DUMAN

Advences in Peritoneal Dialysis, Refereed Journals of Other Institutions, International, 2008, vol 24, pp 32-38